TotalMarketCap

Grifols

GRFSNasdaq SpainHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$5.848 B

$8.51 -1.22%

Close of 6 Nov 2026

As of 6 Nov 2026, Grifols (GRFS) has a market capitalization of $5.85B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #48Mirum PharmaceuticalsMIRM$6.11B
  2. #49Ligand PharmaceuticalsLGND$5.95B
  3. #50GrifolsGRFS$5.85B
  4. #51Belite BioBLTE$5.76B
  5. #52Ptc TherapeuticsPTCT$5.48B

What if Grifols were worth as much as…

Open the what-if tool →

Gold $28.2T

$41,068.54

Per share 4,829× higher

Bitcoin $1.53T

$2,222.15

Per share 261× higher

Apple $5.02T

$7,295.10

Per share 858× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Grifols are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.